Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $113.22 billion. The enterprise value is $129.16 billion.
| Market Cap | 113.22B |
| Enterprise Value | 129.16B |
Important Dates
The last earnings date was Friday, October 30, 2026, before market open.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 4, 2026 |
Share Statistics
Sanofi has 1.20 billion shares outstanding. The number of shares has decreased by -2.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 43.20% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 24.30 and the forward PE ratio is 9.32.
| PE Ratio | 24.30 |
| Forward PE | 9.32 |
| PS Ratio | 1.88 |
| Forward PS | 1.90 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 18.20 |
| P/FCF Ratio | 9.68 |
| P/OCF Ratio | 8.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.58, with an EV/FCF ratio of 11.10.
| EV / Earnings | 26.25 |
| EV / Sales | 2.15 |
| EV / EBITDA | 7.58 |
| EV / EBIT | 9.92 |
| EV / FCF | 11.10 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.12 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 2.01 |
| Interest Coverage | 17.51 |
Financial Efficiency
Return on equity (ROE) is 5.71% and return on invested capital (ROIC) is 9.02%.
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.31% |
| Return on Invested Capital (ROIC) | 9.02% |
| Return on Capital Employed (ROCE) | 10.99% |
| Weighted Average Cost of Capital (WACC) | 5.19% |
| Revenue Per Employee | $773,517 |
| Profits Per Employee | $63,390 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.54 |
Taxes
In the past 12 months, Sanofi has paid $1.95 billion in taxes.
| Income Tax | 1.95B |
| Effective Tax Rate | 29.05% |
Stock Price Statistics
The stock price has decreased by -5.64% in the last 52 weeks. The beta is 0.28, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -5.64% |
| 50-Day Moving Average | 42.22 |
| 200-Day Moving Average | 44.32 |
| Relative Strength Index (RSI) | 76.67 |
| Average Volume (20 Days) | 4,319,902 |
Short Selling Information
The latest short interest is 11.61 million, so 0.97% of the outstanding shares have been sold short.
| Short Interest | 11.61M |
| Short Previous Month | 10.61M |
| Short % of Shares Out | 0.97% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, Sanofi had revenue of $57.89 billion and earned $4.74 billion in profits. Earnings per share was $1.94.
| Revenue | 57.89B |
| Gross Profit | 42.66B |
| Operating Income | 12.55B |
| Pretax Income | 6.71B |
| Net Income | 4.74B |
| EBITDA | 16.43B |
| EBIT | 12.55B |
| Earnings Per Share (EPS) | $1.94 |
Balance Sheet
The company has $6.77 billion in cash and $22.54 billion in debt, with a net cash position of -$15.76 billion or -$13.13 per share.
| Cash & Cash Equivalents | 6.77B |
| Total Debt | 22.54B |
| Net Cash | -15.76B |
| Net Cash Per Share | -$13.13 |
| Equity (Book Value) | 83.17B |
| Book Value Per Share | 68.97 |
| Working Capital | 3.91B |
Cash Flow
In the last 12 months, operating cash flow was $13.45 billion and capital expenditures -$2.23 billion, giving a free cash flow of $11.22 billion.
| Operating Cash Flow | 13.45B |
| Capital Expenditures | -2.23B |
| Depreciation & Amortization | 3.84B |
| Net Borrowing | 1.69B |
| Free Cash Flow | 11.22B |
| FCF Per Share | $9.35 |
Margins
Gross margin is 73.68%, with operating and profit margins of 21.67% and 8.20%.
| Gross Margin | 73.68% |
| Operating Margin | 21.67% |
| Pretax Margin | 11.59% |
| Profit Margin | 8.20% |
| EBITDA Margin | 28.37% |
| EBIT Margin | 21.67% |
| FCF Margin | 19.56% |
Dividends & Yields
This stock pays an annual dividend of $2.42, which amounts to a dividend yield of 5.12%.
| Dividend Per Share | $2.42 |
| Dividend Yield | 5.12% |
| Dividend Growth (YoY) | 10.19% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 133.01% |
| FCF Payout Ratio | 25.90% |
| Buyback Yield | 2.18% |
| Shareholder Yield | 7.35% |
| Earnings Yield | 4.11% |
| FCF Yield | 10.33% |
Analyst Forecast
The average price target for Sanofi is $53.48, which is 13.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $53.48 |
| Price Target Difference | 13.16% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 4.91% |
| EPS Growth Forecast (3Y) | 8.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |